Boehringer Ingelheim Addresses Leucovorin Shortage

Boehringer Ingelheim, parent company of Bedford Laboratories, reports that Bedford is shipping some leucovorin, but that improvements in its manufacturing facilities will cause some short-term interruptions. In a statement, Boehringer Ingleheim says that five lots of intravenous leucovorin were released between late November and mid-December, providing about 175,000 vials.  Another two lots are expect to be…  Read More

Leucovorin Shortage Threatens Colorectal Cancer Treatment

The Food and Drug Administration is reporting shortages of leucovorin calcium, used to enhance the effectiveness of 5-FU (fluorouracil) in treating colorectal cancer.  The reason the FDA gives for the shortage is “Manufacturing Delays.” Leucovorin is supplied by Teva Pharmaceuticals and Bedford Laboratories, and the FDA directs consumers to contact them for more information. According to…  Read More